Nuo Therapeutics AURX
OTC AURX
$1.29 +0.03 (+2.46%)
As of: Oct 21, 2026 · 12:22 PM EDT

Nuo Therapeutics (AURX) Current Debt (2016)

Updated

Analysis

Nuo Therapeutics (AURX) Current Debt (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn -
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn 64.00 Mn
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn 1.93 Bn
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn -
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn 812.00 Mn
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn -
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn 1.68 Bn
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn -291.00 Mn
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn -
10 Nuo Therapeutics 60.54 Mn 58.71 Mn 1.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 2.32 Mn
API Access

Nuo Therapeutics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=AURX&period=max&api_key=YOUR_API_KEY